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In a case-note review of 120 women and 227 men presenting with muscle-invasive bladder tumours in 1998, survival was worse for
women in 3 years of follow-up, with the greatest difference, of 19.9%, at 6 months. For more deprived women, 6-month survival was
52.3%, and 32 (37.2%) presented with advanced disease, compared with 73.5%, and three (8.8%) for less deprived women.
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Bladder cancer is the only common cancer for which women have
worse prognosis than men as reported in the UK, continental
Europe and North America (Micheli et al, 1998; Coleman et al,
1999; Ries et al, 1999). Studies based on routine registry data from
the Netherlands and the US have reported later stage at diagnosis
for women than for men and worse stage-specific survival
(Fleshner et al, 1996; Mungan et al, 2000a,b). These findings are
unexplained. We report the results of a case-note review of patients
with newly diagnosed muscle-invasive bladder cancers to explore
the reasons for differences in survival by sex.
MATERIALS AND METHODS
Patients were eligible if they were diagnosed with a muscle-
invasive bladder carcinoma in 1998, were residents of Greater
Manchester or Lancashire (GML) and had no previous history of
bladder cancer.
All patients in GML diagnosed with a new bladder tumour in
1998 were identified from the database held at the North Western
Cancer Registry, which receives information from all hospitals and
pathology laboratories in GML, and death details from the Office of
National Statistics (ONS). Pathology reports received by the
Registry were reviewed for evidence of muscle-invasive disease
(MID). Case notes were requested if pathology confirmed or
suggested MID, or information was incomplete. In order to
identify patients with a diagnosis of MID based on clinical or
radiological, rather than histological, findings, the case notes of
patients not in the above categories but who either underwent
radiotherapy in 1998 or who died between 1st January 1998 and
31st December 2001 were also requested.
Patients were included in the study if they had MID confirmed
on histology, or they fulfilled one of the following conditions:
residual mass present following resection of a bladder tumour;
bladder mass on scan or ultrasound with bladder cancer
considered the most likely diagnosis; or a large necrotic bladder
tumour on cystoscopy which was not investigated further.
The dates of death were obtained from the Registry, and deaths
were classified into those due to bladder cancer or other causes,
using death certificates and case notes. Stage was determined using
pathology reports and case notes, with clinical staging used for all
analyses. Initially, tumours were staged as T2, T3, T4a or T4b, but
for analyses were classified into advanced (T4b and/or M1) or
nonadvanced. Details of histology and grade were obtained from
pathology reports.
Material deprivation was measured using the Townsend score of
the enumeration district (ED) in which the patient lived,
determined from Registry postcode details. Scores were classified
into five groups based on quintiles for England.
Frequency distributions were compared using w
2 tests and t-
tests. Cause-specific survival rates for bladder cancer were
estimated using the Kaplan–Meier method, with survival mea-
sured from the date of first tumour resection until the date of
death, and censoring on the earlier of date of death due to other
causes, or 30 June 2002; comparisons were made using the log-
rank test. All significance tests were two-sided.
RESULTS
A total of 1190 patients diagnosed with a first bladder tumour in
1998 were identified on the Registry database. Case notes of 754
patients with suspected MID were requested and 676 (90%)
reviewed; 347 were confirmed as having MID without a history of
bladder cancer. In all, 329 patients were excluded: 34 in fact had a
bladder tumour prior to 1998, 14 had tumours other than
carcinomas, 29 had insufficient information on which to base a
diagnosis, nine had insufficient information to stage and 243 had
superficial disease.
Of the study population of 347, 120 (34.6%) were female. The
median age was 75.5 in women and 72.5 in men (t¼1.271; 345 df;
P¼0.205). In all, 78.3% of women and 79.7% of men had either
grade 3 or grade-unknown tumours. A total of 35 (29.2%) women
presented with advanced disease compared with 33 (14.5%) men
(w
2¼10.66; 1 df; Po0.01). Compared with men, women were
under-represented in the two least deprived quintiles (1þ2) and
quintile 4; this difference was not statistically significant
(w
2¼7.987; 4 df; P¼0.092).
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months after diagnosis (Figure 1), was greatest after 6 months
(19.9%), thereafter decreasing to 15.8% at 12 months and 9.9% at 3
years. In total, 49 women and 48 men died from bladder cancer in
the 6-month period following diagnosis (log-rank w
2¼14.74; 1 df;
Po0.01).
When women were categorised according to whether they were
from less deprived (quintiles 1þ2) or more deprived areas (the
remaining quintiles), the 6-month survival was 73.5% for the less
deprived compared with 52.3% for the more deprived (w
2¼4.83; 1
df; Po0.05). Three (8.8%) women from less deprived and 32
(37.2%) from more deprived areas presented with advanced
disease (w
2¼9.50; 1 df; Po0.01) (Table 2). There was no difference
in the age distribution of women from the two deprivation
categories. Neither survival nor stage varied by deprivation for
men (Tables 1 and 2).
DISCUSSION
Women had worse survival than men and were twice as likely to
present with advanced disease. Women from more deprived areas
had worse survival and were more likely to present with advanced
tumours than men or women from less deprived areas.
This population-based study reflects the experience of all
patients diagnosed with new muscle-invasive bladder cancer in
GML in 1998. Clinical staging was used, as less than 20% of
subjects underwent cystectomy: compared with staging based on
examination of cystectomy specimens, this results in the under-
staging of a considerable proportion of tumours (Paik et al, 2000).
However, such misclassification is an implausible explanation for
our finding that advanced disease was proportionally twice as
common in women as men, as one would have to postulate that
clinical and radiological investigations were systematically better
at identifying the early signs of advanced disease in women than in
men.
We found that the difference in survival by sex was greatest 6
months after diagnosis. Other studies have reported the difference
as greatest at 1 year after diagnosis, but none provide results for
periods of less than 1 year (Micheli et al, 1998; Coleman et al, 1999;
Ries et al, 1999; Mungan et al, 2000b). Our results underline the
importance of undertaking a more detailed analysis. The pattern of
survival differences over time in this study – a substantial
difference within 3 months of diagnosis, reaching a maximum
within 6 months – suggests that the most likely explanation for
worse survival in women is that they more commonly present with
advanced disease.
When the superficial tumours (n¼243) are added to our study
population, the difference between the sexes in 1-year survival is
9%, similar to that for England and Wales (Coleman et al, 1999).
Studies from the US and the Netherlands have reported later stage
distribution in women than men and 1-year stage-specific survival
rates 7–16% higher for men (Ries et al, 1999; Mungan et al,
2000a,b). Small decreases in bladder cancer survival (5% in men
and 7% in women) with increasing deprivation have been reported
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Figure 1 Survival from bladder cancer in males and females.
Table 1 6-month survival rates (%) for each deprivation quintile
Quintile Male Female
1 79.5 73.7
2 85.2 73.3
3 78.1 60.9
4 72.8 45.8
5 78.5 50.0
Total 78.4 58.4
Table 2 Number (%) with advanced disease for each deprivation
quintile
Quintile Male Female
1 8 (17.8%) 3 (15.8%)
2 5 (11.9%) 0 (0.0%)
3 4 (12.1%) 9 (31.0%)
4 7 (11.9%) 9 (36.0%)
5 9 (18.8%) 14 (43.8%)
Total 33 (14.5%) 35 (29.2%)
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results on the relationship between stage and deprivation are
from a US hospital-based study, which reported that patients
from low-income neighbourhoods were twice as likely to present
with stage IV bladder cancers as those from high-income
neighbourhoods; results by sex were not presented (Fleshner
et al, 1996).
In this study, the finding of worse survival in females appears to
be confined to women from more deprived areas. The 6-month
survival for this group was 26% lower than for men, compared
with a difference of less than 5% between men and women from
less deprived areas. Three out of eight women with MID from more
deprived areas presented with advanced disease: a much higher
proportion than for men, or less deprived women. Later stage at
diagnosis may be due to faster growing tumours or longer delay in
diagnosis and treatment. Although it is not possible in our study to
determine which of these is the main explanation for later stage
disease in deprived women, longer delay seems the most plausible.
Thus, women from poorer areas with haematuria may be more
likely to delay attending their GP, or symptoms suggestive of
urinary tract infection may be more common among this group,
which could result in delay in referral to a urologist. Further
research is needed to determine how these health inequalities can
be eliminated.
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